Knowledge Center

Patent / Jan 01, 1985

.alpha.-Deoxytetracyclines

Authors:
  • Philip Page
Source:
EP 137661

.alpha.-Deoxytetracyclines I (R = H, OH) were prepd. stereoselectively by reducing methylenetetracyclines II (R = H, OH; R1 = Br, Cl) and III on an aminopropylsilsesquioxane-supported Rh catalyst in the presence of a triarylphosphine. Thus, III (R = OH) was hydrogenated on RhCl3[N[(CH2)3SiO3/2]3]10 in the presence of PPh3 to give 87.4% doxycycline 99.6% pure.

Also in the Knowledge Center

Related Content

Hydrogenations

ËÄÉ«AV has vast experience in developing hydrogenation processes using both heterogeneous and homogeneous catalysis.

Page
Read more

Particle Engineering for Inhalation and Nasal

ËÄÉ«AV is a global expert and recognized leader in particle engineering, an essential technology when developing inhalation drug products.

Page
Read more

ËÄÉ«AV and Zerion Pharma create joint venture to further expand use of Dispersome® technology

Press Release / Oct 03, 2024
Article
View